Background

The Justice Department’s Drug Enforcement Administration has issued a notice proposing the 2020 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act as well as an assessment of annual needs for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. Comments on this proposal are due no later than Oct. 15.

The proposed amounts represent those quantities of the covered substances to be manufactured in the U.S. to provide for the estimated medical, scientific, research, and industrial needs of the U.S.; lawful export requirements; and the establishment and maintenance of reserve stocks. These quotas include imports of ephedrine, pseudoephedrine, and phenylpropanolamine but do not include imports of controlled substances for use in industrial processes.

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.